13 not yet recruiting. 13 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Not yet recruiting 13 |
| Phase 3 | 2 | Not yet recruiting 2 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function | Phase 2 | Not yet recruiting | Foresee Pharmaceuticals Co., Ltd. | 135 | 2027-03-01 | 2026-07-20 |
| Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) Slow Release DHEA, Placebo - Asthma | Phase 2 | Not yet recruiting | Indiana University | 30 | 2027-01-01 | 2026-02-27 |
| Nebulized Ketamine for Severe Asthma Attacks in Children Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma | Phase 2 | Not yet recruiting | Sultan Qaboos University | 60 | 2027-01-01 | 2026-07-27 |
| Ginger's Therapeutic Potential in Asthma Ginger Extract, Placebo - Asthma | Phase 2 | Not yet recruiting | Emily DiMango, MD | 32 | 2026-11-01 | 2026-08-28 |
| A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma JNJ-95597528, Placebo - Asthma | Phase 2 | Not yet recruiting | Janssen Research & Development, LLC | 440 | 2026-10-29 | 2026-09-25 |
| Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy CM512, Placebo - Perennial Allergic Rhinitis (PAR) | Phase 2 | Not yet recruiting | Beijing Keymed Biosciences Co., Ltd. | 200 | 2026-10-01 | 2026-10-22 |
| Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) Stapokibart injection - Seasonal Allergic Rhinitis (SAR) | Phase 2 | Not yet recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 15 | 2026-06-01 | 2026-06-01 |
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis JYB1904, Placebo+JYB1904 - Perennial Allergic Rhinitis | Phase 2 | Not yet recruiting | Jemincare | 135 | 2026-04-01 | 2026-03-09 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis AK139, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Not yet recruiting | Akeso | 111 | 2026-03-02 | 2026-02-27 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma AK139, Placebo - Asthma | Phase 2 | Not yet recruiting | Akeso | 160 | 2026-02-28 | 2026-02-27 |
| Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma SHR4597, Budesonide inhalant - Asthma | Phase 2 | Not yet recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 60 | 2025-04-01 | 2025-04-23 |
| Local Antibiotic Delivery for Community Acquired Pneumonia Levofloxacin, Placebo - Community Acquired Pneumonia (CAP) | Phase 2 / Phase 3 | Not yet recruiting | Copenhagen Respiratory Research | 36 | 2025-03-04 | 2025-03-10 |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract 3,000 MM09, 9,000 MM09, Placebo sublingual - Allergic Rhinitis, Allergic Asthma | Phase 2 / Phase 3 | Not yet recruiting | Inmunotek S.L. | 90 | 2023-11-01 | 2023-10-23 |
Asthma (8) · Rhinitis, Allergic, Perennial (2) · Rhinitis, Allergic, Seasonal (2) · Community-Acquired Pneumonia (1) · Disease (1) · Dust Mite Allergy (1) · Hypersensitivity (1) · Pulmonary Disease, Chronic Obstructive (1) · Rhinitis (1) · Rhinitis, Allergic (1)
Hypersensitivity, Immediate (13) · Immune System Diseases (13) · Respiratory Tract Diseases (13) · Hypersensitivity (12) · Bronchial Diseases (8) · Lung Diseases (8) · Lung Diseases, Obstructive (8) · Nose Diseases (5) · Otorhinolaryngologic Diseases (5) · Rhinitis (4) · Rhinitis, Allergic (4) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Dehydroepiandrosterone (1) · Ketamine (1) · Levofloxacin (1) · ginger extract (1)
Akeso (2) · Beijing Keymed Biosciences Co., Ltd. (1) · Chengdu Kangnuoxing Biopharma,Inc. (1) · Copenhagen Respiratory Research (1) · Emily DiMango, MD (1) · Foresee Pharmaceuticals Co., Ltd. (1) · Guangdong Hengrui Pharmaceutical Co., Ltd (1) · Indiana University (1) · Inmunotek S.L. (1) · Janssen Research & Development, LLC (1) · Jemincare (1) · Sultan Qaboos University (1)
China (5) · Argentina (1) · Oman (1) · United States (1)
Luo Zhang (2) · Bassem Elmankabadi, MD (1) · Chengshuo Wang (1) · Emily DiMango, MD (1) · Jens-Ulrik S. Jensen, Professor, MD, phD (1) · Jorge Fernando Maspero, MD, PhD (1) · Zahraa Ali Al Lawati (1)
P01HL158507 (1), R33AT012627 (1)